Statement of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)	Preferred Stock Series A	Preferred Stock Series B	Preferred Stock Series C	Common Stock	Discount to Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2023	$ 5,000	$ 500	$ 2,000	$ 1,461,615	$ (94,708)	$ 13,749,052	$ (14,192,759)	$ 930,700
Balance (in Shares) at Dec. 31, 2023	5,000,000	500,000	2,000,000	1,461,616,601
Net Loss							(252,580)	(252,580)
Balance at Mar. 31, 2024	$ 5,000	$ 500	$ 2,000	$ 1,461,615	(94,708)	13,749,052	(14,445,339)	678,120
Balance (in Shares) at Mar. 31, 2024	5,000,000	500,000	2,000,000	1,461,616,601
Balance at Dec. 31, 2024	$ 5,000	$ 500	$ 2,000	$ 1,523,619	(94,708)	14,171,048	(15,270,756)	336,703
Balance (in Shares) at Dec. 31, 2024	5,000,000	500,000	2,000,000	1,523,620,126
Common stock issued for warrants				$ 11,769		(11,769)
Common stock issued for warrants (in Shares)				11,768,934
Net Loss							(85,488)	(85,488)
Balance at Mar. 31, 2025	$ 5,000	$ 500	$ 2,000	$ 1,535,388	$ (94,708)	$ 14,159,279	$ (15,356,244)	$ 251,215
Balance (in Shares) at Mar. 31, 2025	5,000,000	500,000	2,000,000	1,535,389,060